DPP4 and metabolic dysfunction-associated steatotic liver disease: Furthermore, KD significantly improved hepatic injury as assessed by ALT release as well as by circulating Dipeptidyl Peptidase-4 (DPP4) (Figure 3B), a metabolic marker strictly associated to MASLD/MASH in both rodents and humans (22).